MedPath

Cross-cultural acceptability of interventions that may increase control at the end of life in patients with dementia

Completed
Conditions
Dementia
major neurocognitive disorder
10042258
Registration Number
NL-OMON54818
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

The person with dementia:
• has a diagnosis of irreversible dementia established by a physician
• has been informed about and is aware of his or her diagnosis
• has a family caregiver (spouse, friend, partner, daughter/son, etc.) who is
willing to participate in the study
• has decision making capacity and is able to communicate through sufficient
memory and language
• has sufficient capacity of the Dutch or English language to participate in
the interview
• is able to understand and sign the consent form
• has adequate vision and hearing (can be achieved by using corrective lenses
and hearing aid if required)
• consents to participate.

The family caregiver:
• is willing and able to participate in the study
• the person with dementia they care for is willing and able to participate
• is at least 18 years old
• has sufficient capacity of the Dutch or English language to participate in
the interview
• consents to participate.

The physician:
• practices a specialty that includes provision of end-of-life care for
individuals living with dementia
• is willing and able to participate in the study
• consents to participate.

Exclusion Criteria

• The person with dementia is currently affected by a severe psychiatric
disorder (e.g., major depression, schizophrenia, substance abuse, PTSD) as
diagnosed by a psychiatrist, psychologist, or physician.
• The person is expected to die in a few weeks

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome is acceptability (i.e., whether the participants would want<br /><br>the interventions at the end of life; patients for themselves, family<br /><br>caregivers for their loved one, and whether physicians would use it at<br /><br>request). Do not know will be a valid response option. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Differences in acceptability between types of interventions, group (role),<br /><br>countries will be investigated, and also, in an explorative manner,<br /><br>associations with other characteristics. Open-ended questions in the interviews<br /><br>will be used to examine, in a qualitative manner, possible ambiguity regarding<br /><br>being in control through the interventions, and as to why and in what situation<br /><br>the respondent feels the interventions are acceptable.</p><br>
© Copyright 2025. All Rights Reserved by MedPath